CUE vs POOL
Cue Biopharma (CUE) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
CUE currently screens at market cap $59.5M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the CUE and POOL stock pages for the full models.
Not investment advice.